Myocardial infarction as a thrombotic complication of myeloproliferative disorders. [PDF]
Petrou E, Karali V.
europepmc +1 more source
Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era [PDF]
Ayalew Tefferi
openalex +1 more source
Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity
Arturo Bonometti+7 more
doaj +1 more source
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. [PDF]
Gupta V+17 more
europepmc +1 more source
Erythrophagocytosis by Myeloid Cells in a Patient with Myeloproliferative Disorder
Sung Ran Cho+2 more
openalex +1 more source
Detection of the Single Hotspot Mutation in the JH2 Pseudokinase Domain of Janus Kinase 2 in Bone Marrow Trephine Biopsies Derived from Chronic Myeloproliferative Disorders [PDF]
Oliver Bock+5 more
openalex +1 more source
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. [PDF]
Sengsayadeth S+24 more
europepmc +1 more source
JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells
Emmanuelle Passegué+2 more
openalex +1 more source
Inconsistencies in the association between JAKV617F mutation and PRV‐1 over‐expression among the chronic myeloproliferative disorders – response to Vannucchi et al [PDF]
Ayalew Tefferi
openalex +1 more source